Ibandronat Spirig HC i.v. 3 mg/3 ml, Injektionslösung

7680654760012 CH-65476 Injektionslösung
Ibandronat Spirig HC i.v. 3 mg/3 ml, Injektionslösung
Ibandronat Spirig HC i.v. 3 mg/3 ml, Injektionslösung
Ibandronat Spirig HC i.v. 3 mg/3 ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
21/03/2024
Summary of Product Characteristics
Français
21/03/2024
Summary of Product Characteristics
Italien
21/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.375 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.63 MG Substance HBESI

Reimbursement information

Public price
CHF 64.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2015

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
65476
Drug name
Ibandronat Spirig HC i.v., Injektionslösung
Galenic form
LSPA
ATC Code
M05BA06
Authorization status
Z
Dispensing category
B
First authorization
28/01/2015
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml
Description (DE)
IBANDRONAT Spirig HC Inj Lös 3 mg/3ml Fertspr 3 ml
Market launch
28/01/2015
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original